Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer.

Oncotarget · 2017 · PMC5652738 · PMID 29100344

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Immunoblotting tumor homogenates for e-cadherin showed a trend to a reduction in e-cadherin expression in tumors from mice treated with gemcitabine.

also in 53,322 other papers

an increasing trendno p-value reported

did not reach statistical significanceno p-value reported

Tumors from mice treated with gemcitabine alone, and in combination with compound-A and with triple therapy also showed an increasing trend to higher Sirius red expression than IgG control mice but these increases did not reach statistical significance.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.